ELF concentrations of ceftriaxone in children with community-acquired pneumonia

Authors

• Yi-Ning Dong, Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
• Ya-Kun Wang, Department of Respiratory Care, Children's Hospital of Hebei Province affiliated to Hebei Medical University, Shijiazhuang, China.
• Qian Li, Department of Clinical Pharmacy, Clinical Trial Center, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, China.
• Bo-Hao Tang, Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
• John van den Anker, Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA.
• Guo-Xiang Hao, Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
• Yi Zheng, Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
• Li-Yuan Tian, Department of Respiratory Care, Children's Hospital of Hebei Province affiliated to Hebei Medical University, Shijiazhuang, China.
• Dian-Ping You, Pediatric Research Institute, Children's Hospital of Hebei Province affiliated to Hebei Medical University, Shijiazhuang, China.
• Yue-E Wu, Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
• Wei Zhao, Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.

Document Type

Journal Article

Publication Date

11-28-2022

Journal

British journal of clinical pharmacology

DOI

10.1111/bcp.15616

Keywords

ELF concentrations; ceftriaxone; children; community-acquired pneumonia

Abstract

Ceftriaxone is widely used in children with community-acquired pneumonia (CAP). Currently, there is no available data regarding epithelial lining fluid (ELF) concentrations of ceftriaxone in children. Thus, Blood and bronchoalveolar lavage fluids (BALF) samples were collected by using an opportunistic sampling design, then we determined plasma and ELF concentrations in 22 children (0.5 - 11.7 years), with a total of 36 plasma and 22 ELF samples available for analysis. Ceftriaxone plasma and ELF concentrations ranged from 1.07 to 138.71 mg/L, and from 0.61 to 26.69 mg/L, respectively. Ceftriaxone concentration in ELF was 12.18 ± 5.15 (mean ± SD) times higher than that in plasma, ranging from 1.29 to 20.44.

APA Citation

Dong, Yi-Ning; Wang, Ya-Kun; Li, Qian; Tang, Bo-Hao; van den Anker, John; Hao, Guo-Xiang; Zheng, Yi; Tian, Li-Yuan; You, Dian-Ping; Wu, Yue-E; and Zhao, Wei, "ELF concentrations of ceftriaxone in children with community-acquired pneumonia" (2022). GW Authored Works. Paper 1892.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/1892

Department

Pediatrics